Skip to content
★ Sign in to follow
BK

Bradford K. Amman

Chief Financial Officer
Vivos Therapeutics, Inc.Lifevantage Corp
Total declarations
5
Companies
2
▲ Purchases (3 ops.)
€18k
▼ Sales (0 ops.)
—

Latest filing published 26 Aug 2026 for Vivos Therapeutics, Inc., €89k.

Filing timeline

BuySale
Bradford K. Amman

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Bradford K. Amman: trading record in brief

Bradford K. Amman, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Vivos Therapeutics, Inc. and Lifevantage Corp. The record holds 5 filings, for trades running from 21 February 2008 to 31 July 2026.

On the market, this insider has only ever bought: 3 purchases, €18k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants.

Half of the purchases are above €6,053 and half below.

The latest filing, published on 26 August 2026, reports a share grant of €89k in Vivos Therapeutics, Inc. The latest purchase dates back some time: it was published 1,993 days ago, on 25 May 2021. Filings reach the SEC (Form 4) feed a median of 10 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Bradford K. Amman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ◆
    Principal Accounting OfficerExecutivesVivos Therapeutics, Inc.
    102,500 USD45SEC
    250,000 shares@ US$0.413.58% mcap95.4% of flowCommon StockSEC:0001493152-26-040238:0
  • ▲
    Chief Financial OfficerExecutivesVivos Therapeutics, Inc.
    5,290 USD31SEC
    1,000 shares@ US$5.294.6% of flowCommon StockSEC:0001493152-21-012902:0
    Canonical exit: 23 Aug 2021 (T+90)
  • ▲
    Chief Financial OfficerExecutivesVivos Therapeutics, Inc.
    7,380 USD0SEC
    1,000 shares@ US$7.38Common StockSEC:0001493152-20-024301:0
    Canonical exit: 24 Mar 2021 (T+90)
  • ▲
    CFO, Treasurer, SecretaryExecutivesLifevantage Corp
    10,000 USD0SEC
    50,000 shares@ US$0.20Common StockSEC:0001209191-09-021167:0
    Canonical exit: 6 Jul 2009 (T+90)
  • ◆
    Treasurer, SecretaryExecutivesLifevantage Corp
    5,007 USD0SEC
    14,307 shares@ US$0.35Common StockSEC:0001209191-08-016802:0

5 of 5 declarations